Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral Immunological Effects of High-dose Vitamin D Treatment in Healthy Subjects
NCT05654818Completed
- Sponsor
- CHU Nîmes
- Start
- Apr 2023
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by CHU Nîmes. Primary endpoints: Change in Lymphocyte T CD4+ cells since baseline at 3 months, Change in T helper1 (Th1) Lymphocyte T CD4+ cells since baseline at 3 months and 22 more. Started Apr 2023; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT05654818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05654818.